|
|
|
Volumn 55, Issue 1416, 2013, Pages 37-39
|
|
Canagliflozin (Invokana) for type 2 diabetes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOGLIPTIN;
CANAGLIFLOZIN;
DAPAGLIFLOZIN;
DIGOXIN;
EXENDIN 4;
GLIMEPIRIDE;
GLIPIZIDE;
GLUCOSE;
HEMOGLOBIN A1C;
HYPERGLYCEMIC AGENT;
INSULIN;
INSULIN DETEMIR;
INSULIN GLARGINE;
INVOKANA;
LINAGLIPTIN;
LIRAGLUTIDE;
METFORMIN;
NATEGLINIDE;
PHENOBARBITAL;
PHENYTOIN;
PIOGLITAZONE;
PLACEBO;
REPAGLINIDE;
RIFAMPICIN;
RITONAVIR;
SAXAGLIPTIN;
SITAGLIPTIN;
SULFONYLUREA;
UNCLASSIFIED DRUG;
GLUCOSIDE;
SLC5A2 PROTEIN, HUMAN;
SODIUM GLUCOSE COTRANSPORTER 2;
THIOPHENE DERIVATIVE;
BLADDER CANCER;
BODY WEIGHT;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG DOSE COMPARISON;
FRACTURE;
GENITAL TRACT INFECTION;
GLOMERULUS FILTRATION RATE;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERGLYCEMIA;
HYPERKALEMIA;
HYPERMAGNESEMIA;
HYPERPHOSPHATEMIA;
HYPERSENSITIVITY;
HYPOGLYCEMIA;
INCIDENCE;
LETTER;
LIFESTYLE MODIFICATION;
MONOTHERAPY;
MYCOSIS;
NAUSEA;
NEPHROTOXICITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREATITIS;
SIDE EFFECT;
SYSTOLIC BLOOD PRESSURE;
URINARY TRACT INFECTION;
WEIGHT GAIN;
ANIMAL;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
METABOLISM;
METHODOLOGY;
REVIEW;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
GLUCOSIDES;
HUMANS;
SODIUM-GLUCOSE TRANSPORTER 2;
THIOPHENES;
|
|
EID: 84877740105
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (16)
|
|
References (4)
|
